Theravance Inc $22.05

up +0.07


22/8/2014 02:22 PM  |  NASDAQ : THRX  
Industries : Drugs / Biotechnology

Insider Transactions

Latest insider trade data based on US Insider Regulatory Filings which are subject to input errors by filers. Insiderslab.com may adjust certain filings for common filing errors on a reasonable effort basis.
Date Name Title Volume Trade Price Holding Change
8/03/2012Winningham Rick EChief Executive Officer80,645$3.1015.45%
7/30/2012BLUM LEONARD MSr VP, Chief Comm. Officer-7,546$29.69-2.63%
5/29/2012Aguiar Michael WSr VP, Chief Financial Officer-20,000$22.29-11.24%
5/20/2012Winningham Rick EChief Executive Officer-10,681$20.33-2.01%
5/20/2012Aguiar Michael WSr VP, Chief Financial Officer-3,832$20.33-2.11%
5/20/2012Brinkley David LHead of Business Dev.-2,402$20.33-2.78%
5/20/2012Mammen MathaiSVP, Research & Early Clin Dev-3,832$20.33-1.59%
5/20/2012Shafer Bradford JSr VP, Gen. Counsel, Secretary-3,832$20.33-1.11%
5/16/2012GLAXOSMITHKLINE PLCSubstantial Shareholder10,000,000$21.2963.23%
5/04/2012Winningham Rick EChief Executive Officer32,258$3.106.87%
5/04/2012Winningham Rick EChief Executive Officer30,967$9.696.17%
5/01/2012DRAZAN JEFFREY MDirector-8,586$21.71-20.42%
2/20/2012Shafer Bradford JSr VP, Gen. Counsel, Secretary-9,621$18.54-2.71%
2/20/2012Mammen MathaiSVP, Research & Early Clin Dev-9,747$18.54-3.89%
2/20/2012Brinkley David LHead of Business Dev.-5,318$18.54-5.80%
2/20/2012Aguiar Michael WSr VP, Chief Financial Officer-10,018$18.54-5.22%
2/20/2012Winningham Rick EChief Executive Officer-21,386$18.54-4.36%
2/14/2012GLAXOSMITHKLINE PLCTenPercent88,468$18.120.56%
12/09/2011Aguiar Michael WSr VP, Chief Financial Officer-10,000$21.86-5.08%
11/20/2011Shafer Bradford JSr VP, Gen. Counsel, Secretary-2,121$22.34-0.62%
11/20/2011Mammen MathaiSVP, Research & Early Clin Dev-2,250$22.34-0.91%
11/20/2011Brinkley David LHead of Business Dev.-1,887$22.34-2.13%
11/20/2011Aguiar Michael WSr VP, Chief Financial Officer-2,532$22.34-1.27%
11/20/2011Winningham Rick EChief Executive Officer-6,218$22.34-1.28%
11/01/2011GLAXOSMITHKLINE PLCTenPercent58,411$22.230.37%
9/01/2011Mammen MathaiSVP, Research & Early Clin Dev3,225$8.531.32%
8/20/2011Shafer Bradford JSr VP, Gen. Counsel, Secretary-2,120$17.50-0.62%
8/20/2011Mammen MathaiSVP, Research & Early Clin Dev-2,248$17.50-0.91%
8/20/2011Brinkley David LHead of Business Dev.-1,889$17.50-2.09%
8/20/2011Aguiar Michael WSr VP, Chief Financial Officer-2,532$17.50-1.25%
8/02/2011GLAXOSMITHKLINE PLCTenPercent102,466$19.710.66%
6/14/2011Aguiar Michael WSr VP, Chief Financial Officer-14,225$22.94-6.58%
6/07/2011DRAZAN JEFFREY MDirector-31,907$23.29-40.78%
6/06/2011DRAZAN JEFFREY MDirector-37,344$23.08-32.31%
5/31/2011Brinkley David LHead of Business Dev.-51,500$25.65-36.28%
5/31/2011Brinkley David LHead of Business Dev.44,402$9.6946.01%
5/31/2011Brinkley David LHead of Business Dev.1,039$18.370.74%
5/27/2011Brinkley David LHead of Business Dev.-57,812$25.31-37.47%
5/27/2011Brinkley David LHead of Business Dev.52,371$9.6951.38%
5/27/2011Brinkley David LHead of Business Dev.2,789$3.102.81%
5/27/2011Brinkley David LHead of Business Dev.2,652$3.102.75%
5/20/2011Brinkley David LHead of Business Dev.-1,883$25.48-1.91%
5/20/2011Mammen MathaiSVP, Research & Early Clin Dev-2,245$25.48-0.90%
5/20/2011Aguiar Michael WSr VP, Chief Financial Officer-2,527$25.48-1.16%
5/20/2011Shafer Bradford JSr VP, Gen. Counsel, Secretary-2,116$25.48-0.61%
5/11/2011Winningham Rick EChief Executive Officer-73,100$26.28-13.08%
5/10/2011Winningham Rick EChief Executive Officer-54,646$26.41-8.91%
5/03/2011GLAXOSMITHKLINE PLCTenPercent261,299$25.604.43%
3/16/2011Brinkley David LHead of Business Dev.-2,100$22.02-2.09%
3/16/2011Brinkley David LHead of Business Dev.2,100$3.102.13%
3/15/2011Brinkley David LHead of Business Dev.3,931$3.102.81%
3/15/2011Brinkley David LHead of Business Dev.3,290$3.102.41%
3/15/2011Brinkley David LHead of Business Dev.-45,492$22.08-31.62%
3/15/2011Brinkley David LHead of Business Dev.38,271$8.5338.90%
3/11/2011Shafer Bradford JSr VP, Gen. Counsel, Secretary-6,451$22.75-100.00%
3/11/2011Shafer Bradford JSr VP, Gen. Counsel, Secretary-20,238$22.76-5.51%
3/07/2011YOUNG WILLIAM DDirector10,752$8.5337.39%
3/07/2011YOUNG WILLIAM DDirector-5,376$22.31-13.61%
3/01/2011Winningham Rick EChief Executive Officer-63,873$22.53-9.43%
2/28/2011Winningham Rick EChief Executive Officer-29,800$22.49-4.00%
2/28/2011Winningham Rick EChief Executive Officer-37,200$23.49-5.20%
2/28/2011Winningham Rick EChief Executive Officer101,752$8.5315.83%
2/25/2011Winningham Rick EChief Executive Officer-42,000$22.74-6.13%
2/25/2011Winningham Rick EChief Executive Officer-50,200$22.22-6.83%
2/25/2011Winningham Rick EChief Executive Officer135,850$8.5322.67%
2/24/2011Winningham Rick EChief Executive Officer135,950$8.5324.44%
2/24/2011Winningham Rick EChief Executive Officer-93,100$21.45-13.45%
2/23/2011Winningham Rick EChief Executive Officer142,500$8.5327.87%
2/23/2011Winningham Rick EChief Executive Officer-97,600$21.14-14.93%
2/22/2011Winningham Rick EChief Executive Officer-158,500$21.43-23.30%
2/22/2011Winningham Rick EChief Executive Officer11,729$8.532.78%
2/22/2011Winningham Rick EChief Executive Officer246,411$8.5356.81%
2/22/2011Winningham Rick EChief Executive Officer-10,300$22.15-1.97%
2/20/2011Shafer Bradford JSr VP, Gen. Counsel, Secretary-3,111$22.50-0.84%
2/20/2011Brinkley David LHead of Business Dev.-2,480$22.50-2.46%
2/20/2011Mammen MathaiSVP, Research & Early Clin Dev-3,240$22.50-1.28%
2/20/2011Winningham Rick EChief Executive Officer-6,790$22.50-1.58%
2/20/2011Aguiar Michael WSr VP, Chief Financial Officer-3,511$22.50-1.58%
2/18/2011YOUNG WILLIAM DDirector-5,376$23.22-15.75%
2/18/2011YOUNG WILLIAM DDirector10,752$8.5345.99%
2/18/2011GLAXOSMITHKLINE PLCTenPercent152,278$23.702.65%
2/18/2011Mammen MathaiSVP, Research & Early Clin Dev-3,701$23.12-1.44%
1/28/2011Mammen MathaiSVP, Research & Early Clin Dev9,838$8.537.34%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (THRX), click here.
Trading Center